UPDATE: Laidlaw Starts NLS Pharmaceutics (NLSP) at Buy
Tweet Send to a Friend
(Updated - September 6, 2022 5:19 AM EDT)
Laidlaw analyst Yale Jen initiates coverage on NLS Pharmaceutics (NASDAQ: NLSP) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Laidlaw analyst Yale Jen initiates coverage on NLS Pharmaceutics (NASDAQ: NLSP) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
